Physicians office Resource 2019 Issue 9
™
Resources for You, Your Patients, & Your Practice
ESR RESULTS IN SECONDS The New miniiSED™
Page 4
also in this issue LabOratory: Planning for New Instruments / New Tests Page 6 The Importance of RSV Testing Page 22
MDescapes: Luxurious Getaways and Special Offers Exclusively for Physicians Page 25 Healthy Skepticism: Helping Patients Help Themselves Online Page 36
2019 Issue 9
Physicians office Resource™
PHYSICIANS office RESOURCE
Resources for You, Your Patients, & Your Practice Published by Medical Education Resources, LLC Publisher Aaron R. Medaris amedaris@physiciansofficeresource.com CEO Andrew C. Nimmo acnimmo@physiciansofficeresource.com President John D. Pasquale jpasquale@pharmaconnect.com Business Manager Marci J. Hills mhills@physiciansofficeresource.com
GETTING THE MOST FROM THIS GUIDE There are two simple ways to request information about the products and services found in Physicians Office Resource.
A B
Go to www.PhysiciansOfficeResource.com and enter the four-digit reference number found next to the product or service into the search field, then request additional information, schedule a demo, or speak with a sales agent all with just a simple click of a button.
2
Find the Business Reply Card in this issue, circle the desired reference numbers, complete the form, and drop into any USPS mailbox. A representative will contact you as quickly as possible to answer your questions.
www.PhysiciansOfficeResource.com
Travel Editor Brandi L. Brower Editorial Board Michael Paquin, FHIMSS Barry Craig, MLT (NCA), CLC Staff Writer Dylan J. Chadwick
Copyright ©2019
To continue your free subscription of Physicians Office Resource magazine, please fill out the Business Reply Card (BRC) located within this magazine and drop in any United States Post Office mailbox. If you are a manufacturer of medical products or provide services to medical professionals and would like to advertise your products or services to the nation’s top physicians doing in-office testing, call 801-380-6094 or visit: POR.io for more information.
Thank you!
6900
2019 Issue 9
PHYSICIANS office RESOURCE
Physicians office Resource ™
table of contents
MDescapes Luxurious Getaways & Exclusive Deals for POR Magazine Readers
25
articles in this issue 6901
ESR Results in Seconds miniiSED™ is the newest addition to the iSED® family of Erythrocyte Sedimentation Rate (ESR) analyzers from ALCOR Scientific. The miniiSED™ measurement of ESR is fast, accurate and unaffected by variables associated with traditional methodologies, such as hematocrit. This single position, fully automated ESR analyzer works directly from primary EDTA tubes or BD Microtainer® MAP Microtubes, requires 100 microliters of sample, has an internal barcode reader, and produces results in 15 seconds! The miniiSED’s small footprint combined with its advanced design and rapid time to result makes it the ideal solution to ESR testing for small laboratories, POL’s, and emergency clinics. Proudly manufactured in the USA. 6901 4
Planning for New Instruments / New Tests
6
Whether planning a new, start-up laboratory operation, or performing an analysis of current testing, (providing input for decisions on whether or not to purchase new or replacement...
The Importance of RSV Testing
22
Many Americans have probably never heard of respiratory syncytial virus (RSV), despite the fact that the CDC issued a warning in late 2018 cautioning parents of children...
Helping Patients Help Themselves Online
36
These days, virtually any brick and mortar service has its own internet doppleganger. One can attain a college degree by attending...
Get more of the story, faster. Improve patient flow with on-site, syndromic gastrointestinal disease testing from BioFire. Waiting hours or days for laboratory results for gastroenteritis can make patient management decisions complicated. The BioFireÂŽ FilmArrayÂŽ Gastrointestinal (GI) Panel simultaneously tests for 22 of the most commonly associated pathogens related to gastroenteritis. And now, tests can be performed right in the office.*
6902
Faster Diagnosis. Better Patient Care. Shorten Time to Results With results in about one hour, you can diagnose patients faster and possibly reduce further medical follow-up. Improve Operational Efficiency The BioFire GI Panel is easy-to-use, it takes just two minutes of hands-on time and 0.2 mL sample in Cary Blair. Prescribe the Right Treatment Improve your Antimicrobial Stewardship Program by aiding in more accurate and timely diagnosis and potentially reducing unnecessary antibiotic prescriptions.
biofiredx.com
*CLIA moderate complexity certification is required
BFR0000-2962-01
2019 Issue 9
PHYSICIANS office RESOURCE
PLANNING FOR NEW INSTRUMENTS / NEW TESTS Irwin Z. Rothenberg, MBA, MS, CLS(ASCP) Technical Writer /Quality Advisor, COLA Resources, Inc.
Whether planning a new, start-up laboratory operation, or performing an analysis of current testing, (providing input for decisions on whether or not to purchase new or replacement instruments, or add or delete tests), it is important to do a realistic assessment not only of what you want to offer your ordering physicians, but what you can realistically offer. The laboratory’s test menu should be aligned as closely as possible with physician expectations and needs, as well as the laboratory’s operational capabilities. By strengthening relationships with ordering physicians, laboratories can more accurately forecast future service needs and make the best decisions as to test menu, instrumentation, and staffing, including which tests to outsource or maintain in-house. Begin this process by: Reviewing Basic Information about the Current / Proposed Laboratory Operation The first step in the planning process for adding new tests and new instrumentation begins with asking the following baseline questions regarding the present or proposed laboratory operation: • What is your present test menu? Present instrumentation? Present staffing levels? • What medical specialties are represented by your ordering physicians? (an important determinant of what tests will be requested, as well as patient demographics) • Do you anticipate changes in the number of client physicians served? New specialties added? New populations served? 6
www.PhysiciansOfficeResource.com
•
What are your current or anticipated test volumes / demand for specific tests? • What is the complexity of testing already performed or planned? (waived vs. non-waived, with attendant regulatory requirements, including personnel) • What are your present hours of operation with attendant staffing levels / type and volume of testing performed per shift / commitment for turn-around times? • What are your anticipated operating and capital budgets? (important determinant for changes to instrumentation and level of automation; as well as staffing expertise) • Is adequate work space available to accommodate all phases of new patient testing from specimen collection to test result reporting? The answers to these questions provide guidance for any changes to the test menu, which will be a driver for decisions on whether to acquire new or replacement instruments. The next step forward is to perform a Cost/Benefit analysis of your present operation, and of the proposed changes to the test systems to determine economic and logistical feasibility. Determine the Feasibility of Adding New Tests: Perform a Cost / Benefit Analysis It is by taking into account the internal as well as external factors in the laboratory environment, that the decisions made will have the best chance of success.
Below are items to consider for your cost/benefit analysis: / payment mechanisms? • Instrument capacity for current or proposed test menu • What is the current market for your laboratory (is it “right-sized” for test volume and level of staffing) services? Estimating market size and location is a • Instrument cost (purchase or lease) critical component to determine market opportunity. • Reagent cost (are you obligated to purchase reagents These estimates will drive financial outcomes. from a particular manufacturer?) • If you are part of an organization that has adopted • Reagent life (expiration the concept of dates: days, weeks, months value-based “Of course, providing the highest before/after opening medical care, and level of service for your patients may packages) it now part of justify costs associated with the • Storage requirements for an Accountable above considerations, but it is vital reagents (do you need to Care to ensure that your instrumentation buy a new refrigerator or Organization can handle the changes in projected freezer?) (ACO), or demand in terms of test volume • Frequency and expense accepts “bundled capacity, variety of tests offered, of Quality Controls, payments”, Calibration, and your expenses operating times and staffing.” Maintenance will come Irwin Z. Rothenberg • Tests run singly or in under increased batch-mode pressure to be • Comparison of in-house testing with reference held down and minimized. You may be encouraged to laboratory charges and turn-around time outsource more than originally planned. • Complexity of present and proposed testing. • The well-documented staffing shortage may be a • Staffing requirements: number, training expenses; factor in your area; consider your local situation if qualifications and experience beyond present staffing; planning to increase testing, add shifts, and new precontinuing education analytic services. • Proficiency Testing requirements Of course, providing the highest level of service for • Facility space, ventilation, electrical needs; hazardous your patients may justify costs associated with the disposal requirements above considerations, but it is vital to ensure that your • Time and involvement of the Lab Director, and the instrumentation can handle the changes in projected Technical Consultant demand in terms of test volume capacity, variety of tests • Document storage requirements / LIS capability offered, operating times and staffing. This may require • Adjusting the front office staffing to handle additional considering more automation. Automation has long been pre and post analytical paperwork and communications regarded as an important means for clinical laboratories Additional strategies to determine the to achieve greater operational efficiency, test accuracy, appropriateness of testing offered, and the method standardization, total data handling and reduced instrumentation needed. turnaround time; in short, an improved quality of • Analyze test mix and outsource demanded but lowpatient care. volume tests. Only outsource these tests if you can The development of new generations of automated provide the test results a lower cost and with a better stand-alone and bench top equipment has made turnaround time. automation a more viable option for labs of all sizes— • Project test demand and costs to determine which and in many cases, a necessary option for labs seeking to tests to perform in house. Conversely, analysis of remain competitive in today’s marketplace. send-out volumes may indicate opportunities to bring Steps in Determining the Right Automation for certain tests in-house. Your Laboratory • Partner with reference laboratories. Reference A. Questions to ask when deciding how much laboratories can provide valuable support in the form automation is needed of financial analysis, methodology assessment, and The amount of automation needed depends on the provision of clinical samples to help make in-sourcetype and size of your laboratory. If all you are looking versus-outsource decisions and to establish and for is increased throughput and you don’t really have to increase on-site test volumes. deal with diverse assays and readouts, then you might Consider external factors as well want to think about modular components. So with a • Consider what is going on in the laboratory industry few nonintegrated pieces of equipment, you can get today, noting trends both locally and across the country the throughput you need without a huge investment, or and seeing if these factors may affect your laboratory: additional space required... • What will be the impact of changes in reimbursement Read this and other articles at www.PhysiciansOfficeNews.com
7
6903
FIRST EVER CLIA WAIVED HEMATOLOGY ANALYZER
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
From Sysmex
Faster test results, clinical decisions and greater practice efficiency are coming to physicians’ offices with the first CLIA-waived CBC analyzer. Hematology diagnostics leader Sysmex is bringing more lab testing to the point of care. One of the most common blood tests can be conducted reliably and accurately on-site, in as few as three minutes. The device’s ease of use and innovative technology means in-house staff can operate it in just a few easy steps, without lengthy certification and training. The new Sysmex XW100 will improve health care efficiency and patient care.
View Brochures, Videos & Mores at POR.io Enter Number 6903 in the Search Area
6904
COST-EFFECTIVE AI MEDICAL SCRIBE From Phraze
Are you frustrated with spending more time writing notes than seeing patients? Has the EHR become a “screen between” you and your patients? Are you interested in having a medical scribe, but find that the cost is prohibitive? Phraze’s is a cost-effective AI Medical Scribe software that analyzes the conversation between you and your patient. It then automatically produces a clinical note that is as beautiful as it is intelligent: saving you time and improving your connection to patients.
View Brochures, Videos & Mores at POR.io Enter Number 6904 in the Search Area
6905
BREWER’S FLEX™ ACCESS EXAM TABLE From Brewer
Step up to power table performance for less with Brewer’s Flex™ Access Exam Table. Industry-leading 700-lb. patient weight capacity, unique safety features and unmatched ergonomic patient access maximize your clinical efficiency and ROI. A streamlined footprint and optional upgrades like safety grab bars, stirrups, and pass-through work surface provide ultimate flexibility for your practice.
View Brochures, Videos & Mores at POR.io Enter Number 6905 in the Search Area
8
www.PhysiciansOfficeResource.com
Take advantage of these Take advantage of these Take advantage of these HOT fall deals! autumn deals! AWESOME HOT fall deals! Save your cash. Ask us about flexible leasing options.
Save your cash. Ask us about flexible leasing options. Purchase a Micros ES 60 3-Part Diff Hematology Analyzer and a LiteDM Data Management System, Purchase aget Micros ES 60 3-Part Diff Hematology three extra connections1 at no additional charge DM 6906
C
M
+
Analyzer and a Lite Data Management System, get three extra connections1 at no additional charge Connect up to 4 analyzers with one LiteDM
+
=
= Connect up to 4 analyzers with one Lite
Includes connections for the Micros 60 and any 3rd party DM analyzers of your choice where connections are already available
Includes connections for the Micros 60 and any Micros ES 60 3-Part Diff LiteDM Patient Data Management analyzers of your choice where connections are Hematology Analyzer
3rd party already available
Y
Patient Dataa Micros ES 60 3-Part Diff LiteDMPurchase Management Hematology Analyzer CM
MY
CY
Pentra 60C+ or a Pentra XL80 5-Part Diff Hematology Analyzer, get service at no additional charge when you purchase Calibrators and Controls for 60 months
Purchase a Pentra 60C+ or a Pentra XL80 5-Part Diff Hematology Analyzer, 6907 get service at no additional charge when you purchase Calibrators and Controls for 60 months CMY
K
Pentra 60 C+ 5-Part Diff Hematology Analyzer
Pentra XL80+ 5-Part Diff Hematology Analyzer
Purchase a Pentra C400 Chemistry Analyzer, get a Micros 60 3-Part Diff Hematology Analyzer Pentra 60 C+ 5-Part Diff Pentra XL80+ 5-Part Diff DM at no additional charge and a Lite Hematology AnalyzerData Management System Hematology Analyzer
Purchase a Pentra C400 Chemistry Analyzer, 6908 get a Micros 60 3-Part Diff Hematology Analyzer and a LiteDM Data Management System at no additional charge
+
+
Pentra C400 Chemistry Analyzer
+
+
=
=
LiteDM Patient Data Management
Micros 60 3-Part Diff Hematology Analyzer
To request pricing and more information, e-mail medical-marketing.US@horiba.com
All offers expire December 31, 2019. All terms and conditions apply. 1 Connections must be installed at time of analyzer installation
Pentra C400 Contact Chemistry Analyzer
One Great Deal!
One Great DM Patient Data Horiba Medical •Lite medical-marketing.US@horiba.com Microsat 60888-280-1401 3-Part Diff Hematology Analyzer
All offers expire December 31, 2019. All terms and conditions apply. 1 Connections must be installed at time of analyzer installation
Deal!
Management
To request pricing and more information, e-mail medical-marketing.US@horiba.com
Contact Horiba Medical at 888-280-1401 • medical-marketing.US@horiba.com
Jacob’s birthday party No, my migraine wants me to lie down in the dark Yes, I will attend
Š 2019 Teva Pharmaceuticals USA, Inc.
FRE-41678
March 2019
Less migraine. More moments.
TM
Help patients say yes to more moments AJOVY® (fremanezumab-vfrm) injection is the only anti-CGRP treatment for the prevention of migraine with quarterly and monthly dosing options1 More migraine-free days with AJOVY in clinical trials1
INDICATION
AJOVY is indicated for the preventive treatment of migraine in adults.
IMPORTANT SAFETY INFORMATION
Contraindications: AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients. Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Most reactions were reported from within hours to one month after administration. If a hypersensitivity reaction occurs, consider discontinuing AJOVY and institute appropriate therapy. Adverse Reactions: The most common adverse reactions (≥5% and greater than placebo) were injection site reactions. Please see Brief Summary of full Prescribing Information on the following page.
To learn more, visit AJOVYhcp.com
CGRP: calcitonin gene-related peptide. Reference: 1. AJOVY® (fremanezumab-vfrm) injection Current Prescribing Information. North Wales, PA: Teva Pharmaceuticals USA, Inc.
BRIEF SUMMARY OF PRESCRIBING INFORMATION FOR AJOVY® (fremanezumab-vfrm) injection, for subcutaneous use SEE PACKAGE INSERT FOR FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE AJOVY is indicated for the preventive treatment of migraine in adults. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage Two subcutaneous dosing options of AJOVY are available to administer the recommended dosage: • 225 mg monthly, or • 675 mg every 3 months (quarterly), which is administered as three consecutive subcutaneous injections of 225 mg each. When switching dosage options, administer the first dose of the new regimen on the next scheduled date of administration. If a dose of AJOVY is missed, administer as soon as possible. Thereafter, AJOVY can be scheduled from the date of the last dose. 2.2 Important Administration Instructions AJOVY is for subcutaneous use only. AJOVY may be administered by healthcare professionals, patients, and/or caregivers. Prior to use, provide proper training to patients and/or caregivers on the preparation and administration of AJOVY prefilled syringe, including aseptic technique [see Instructions for Use in full Prescribing Information]: • Remove AJOVY from the refrigerator. Prior to use, allow AJOVY to sit at room temperature for 30 minutes protected from direct sunlight. Do not warm by using a heat source such as hot water or a microwave. Do not use AJOVY if it has been at room temperature for 24 hours or longer. • Follow aseptic injection technique every time AJOVY is administered. • Inspect AJOVY for particles or discoloration prior to administration. Do not use if the solution is cloudy, discolored, or contains particles. • Administer AJOVY by subcutaneous injection into areas of the abdomen, thigh, or upper arm that are not tender, bruised, red, or indurated. For multiple injections, you may use the same body site, but not the exact location of the previous injection. • Do not co-administer AJOVY with other injectable drugs at the same injection site. 4 CONTRAINDICATIONS AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumabvfrm or to any of the excipients [see Warnings and Precautions (5.1)]. 5 WARNINGS AND PRECAUTIONS 5.1 Hypersensitivity Reactions Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria, were reported with AJOVY in clinical trials. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Most reactions were reported from within hours to one month after administration. If a hypersensitivity reaction occurs, consider discontinuing AJOVY, and institute appropriate therapy. 6 ADVERSE REACTIONS The following clinically significant adverse reactions are discussed in greater detail in other sections of the labeling: • Hypersensitivity Reactions [see Warnings and Precautions (5.1)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug, and may not reflect the rates observed in clinical practice. The safety of AJOVY was evaluated in 2512 patients with migraine who received at least 1 dose of AJOVY, representing 1279 patient-years of exposure. Of these, 1730 patients were exposed to AJOVY 225 mg monthly or AJOVY 675 mg quarterly for at least 6 months, 775 patients for at least 12 months, and 138 patients for at least 15 months. In placebo-controlled clinical trials (Studies 1 and 2), 662 patients received AJOVY 225 mg monthly for 12 weeks (with or without a loading dose of 675 mg), and 663 patients received AJOVY 675 mg quarterly for 12 weeks. In the controlled trials, 87% of patients were female, 80% were White, and the mean age was 41 years. The most common adverse reactions in the clinical trials for the preventive treatment of migraine (incidence at least 5% and greater than placebo) were injection site reactions. The adverse reactions that most commonly led to discontinuations were injection site reactions (1%). Table 1 summarizes adverse reactions reported in the 3-month placebo-controlled studies (Study 1 and Study 2), and the 1-month follow-up period after those studies. Table 1: Adverse Reactions Occurring with an Incidence of At Least 2% for Either Dosing Regimen of AJOVY and At Least 2% Greater Than Placebo in Studies 1 and 2 Placebo AJOVY AJOVY Monthly 225 mg Monthly 675 mg Quarterly (n=668) (n=667) (n=290) % % % Injection site reactionsa 43 45 38 a Injection site reactions include multiple related adverse event terms, such as injection site pain, induration, and erythema. Adverse Reaction
AJOVY® (fremanezumab-vfrm) injection 6.2 Immunogenicity As with all therapeutic proteins, there is a potential for immunogenicity. The detection of antibody formation is highly dependent on sensitivity and specificity of the assay. Additionally, the observed incidence of antibody (including neutralizing antibody) positivity in an assay may be influenced by several factors, including assay methodology, sample handling, timing of sample collection, concomitant medications, and underlying disease. For these reasons, comparison of the incidence of antibodies to fremanezumab-vfrm in the studies described below with the incidence of antibodies in other studies to other products may be misleading. Clinical immunogenicity of AJOVY was monitored by analyzing anti-drug antibodies (ADA) and neutralizing antibodies in drug-treated patients. The data reflect the percentage of patients whose test results were positive for antibodies to AJOVY in specific assays. In 3-month placebo-controlled studies, treatment-emergent ADA responses were observed in 6 out of 1701 (0.4%) AJOVY-treated patients. One of the 6 patients developed anti-AJOVY neutralizing antibodies at Day 84. In the ongoing long-term open-label study, ADA were detected in 1.6% of patients (30 out of 1888). Out of 30 ADA-positive patients, 17 had a neutralizing activity in their post-dose samples. Although these data do not demonstrate an impact of antifremanezumab-vfrm antibody development on the efficacy or safety of AJOVY in these patients, the available data are too limited to make definitive conclusions. 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Risk Summary There are no adequate data on the developmental risk associated with the use of AJOVY in pregnant women. AJOVY has a long half-life. This should be taken into consideration for women who are pregnant or plan to become pregnant while using AJOVY. Administration of fremanezumab-vfrm to rats and rabbits during the period of organogenesis or to rats throughout pregnancy and lactation at doses resulting in plasma levels greater than those expected clinically did not result in adverse effects on development [see Animal Data]. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. The estimated rate of major birth defects (2.2-2.9%) and miscarriage (17%) among deliveries to women with migraine are similar to rates reported in women without migraine. Clinical Considerations Disease-Associated Maternal and/or Embryo/Fetal Risk Published data have suggested that women with migraine may be at increased risk of preeclampsia during pregnancy. Data Animal Data When fremanezumab-vfrm (0, 50, 100, or 200 mg/kg) was administered to male and female rats by weekly subcutaneous injection prior to and during mating and continuing in females throughout organogenesis, no adverse embryofetal effects were observed. The highest dose tested was associated with plasma exposures (AUC) approximately 2 times that in humans at a dose of 675 mg. Administration of fremanezumab-vfrm (0, 10, 50, or 100 mg/kg) weekly by subcutaneous injection to pregnant rabbits throughout the period of organogenesis produced no adverse effects on embryofetal development. The highest dose tested was associated with plasma AUC approximately 3 times that in humans (675 mg). Administration of fremanezumab-vfrm (0, 50, 100, or 200 mg/kg) weekly by subcutaneous injection to female rats throughout pregnancy and lactation resulted in no adverse effects on pre- and postnatal development. The highest dose tested was associated with plasma AUC approximately 2 times that in humans (675 mg). 8.2 Lactation Risk Summary There are no data on the presence of fremanezumab-vfrm in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for AJOVY and any potential adverse effects on the breastfed infant from AJOVY or from the underlying maternal condition. 8.4 Pediatric Use Safety and effectiveness in pediatric patients have not been established. 8.5 Geriatric Use Clinical studies of AJOVY did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Manufactured by: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454 US License No. 2016 ©2019 Teva Pharmaceuticals USA, Inc. This Brief Summary is based on the full Prescribing Information for AJOVY AJO-002.
FRE-41620
March 2019
PRODUCTFOCUS 6909
LASER LIPO–NON-INVASIVE INSTANT INCH LOSS RESULTS From Laser Lipo Ltd
The FDA Approved, Strawberry Laser Lipo is a groundbreaking treatment offering non-invasive, instant inch loss results to the Abdomen, Hips, Thighs, Arms, Back Fat, Buttocks, Male Chest and Knees, without any pain or downtime. The clinically proven, non-invasive laser treatment penetrates the skin to selectively target the fat cells underneath, leaving blood vessels, nerves and other tissue undisturbed. Only $24,750 and 0% in-house no credit check financing.
View Brochures, Videos & Mores at POR.io Enter Number 6909 in the Search Area
RELIABLE DETECTION OF STREP A, FLU A, FLU B AND RSV
6910
From Cepheid
Cepheid’s GeneXpert Xpress® brings standardized molecular testing to any healthcare setting. Employing the highly accurate and easy to use lab in a cartridge technology in every GeneXpert system, the GeneXpert Xpress® is a true on-demand walkaway testing system that provides accurate and reliable detection of Strep A, Flu A, Flu B and RSV. Two or four-module configurations save valuable bench space and reduce the need for multiple testing platforms.
View Brochures, Videos & Mores at POR.io Enter Number 6910 in the Search Area
SILARIS™ INFLUENZA A&B TEST 6911
From Sekisui Diagnostics
A molecular test utilizing polymerase chain reaction (PCR) technology providing accurate results for early diagnosis and proper management of influenza. Accurate √ Molecular Results √ State-of-the art microfluidic cassette technology √ PCR test using proprietary OscAR™ Technology Affordable √ Single Test Diagnosis √ Controls in every kit √ Molecular reimbursement (CPT Code 87502) Simple √ Easy to Use √ Compact portable dock with no calibration required √ Room temperature storage
View Brochures, Videos & Mores at POR.io Enter Number 6911 in the Search Area
www.PhysiciansOfficeResource.com
13
6912
SELF-CONTAINED DIAGNOSTIC WORKSTATION From Vitalograph
Vitalograph introduces the Compact Expert diagnostic workstation. The device is a full touch-screen based medical workstation, which comes equipped with Vitalograph’s flagship Pneumotrac spirometer. This accurate, robust and linear Fleisch pneumotach produces over 50 spirometry parameters, automatically stores all test data, calibration data and clinical audit trail data in a secure network capable SQL Server database. An intuitive user interface enhances the routine workflow in most practices, allowing quick patient throughput. Beyond spirometry, it is a desktop testing station for ECG, Pulse Oximetry, Weight , COPD assessment, and Blood Pressure measurements.
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
View Brochures, Videos & Mores at POR.io Enter Number 6912 in the Search Area
6913
THE SILARIS® RSV TEST From Sekisui Diagnostics
The Silaris® RSV Test is a molecular diagnostic test utilizing polymerase chain reaction (PCR) technology providing accurate results to aid in early diagnosis and proper management of RSV. The system is easy to use, compact, portable and CLIA Waived so you can test and treat in one visit.
View Brochures, Videos & Mores at POR.io Enter Number 6913 in the Search Area
6914
THE RX IMOLA From Randox
A fully automated, random access analyzer with STAT sampling functionality; boosting productivity and saving time when it matters most. Developed for medium-high throughput laboratories, the RX imola provides comprehensive testing with the world-class RX series test menu, including specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing. The RX imola: A cost-effective system that delivers consistent high quality results with a small footprint.
View Brochures, Videos & Mores at POR.io Enter Number 6914 in the Search Area 14
www.PhysiciansOfficeResource.com
Systems for Clinical Laboratories, Large and Small CHEMISTRY
6915
Chemistry: Up to 240 photometric tests/hr; 400 tests/hr with ISE
IMMUNOASSAY
HEMATOLOGY
SMALL PRACTICES / BENCHTOP
6916
6917
BC-3600 Immunoassay: Up to 36 tests/hr
Hematology: Up to 60 samples/hr 3-Part Diff
MIDSIZE GROUP PRACTICES 6918
6919
6920
BC-5390 Chemistry: Up to 400 photometric tests/hr; 800 tests/hr with ISE
With 9-Tray Sorter Immunoassay: Up to 90 tests/hr
Hematology: Up to 60 samples/hr 5-Part Diff
LARGE GROUP PRACTICES AND SMALL HOSPITALS 6921
6922
6923
BC-5390 Chemistry: Up to 900 photometric tests/hr; 1,200 tests/hr with ISE
With 19-Tray Sorter Immunoassay: Up to 90 tests/hr
Hematology: Up to 60 samples/hr 5-Part Diff
www.carolinachemistries.com contactsales@carolinachemistries.com
877-722-8910 888-442-8303 POR_back_cover_ad.00 JUN 2019
2019 Issue 9
PRODUCTFOCUS
PHYSICIANS office RESOURCE
6924
THE BREWER BASIC EXAM TABLE From Brewer
Full featured, entry-level exam table design. The Brewer Basic Exam Table features a pneumatic cylinder, seamless upholstery, and the largest storage capacity available. We invite you to compare features, price, warranty and you will find the Brewer Basic Exam Table is clearly the best entry level exam table available.
View Brochures, Videos & Mores at POR.io Enter Number 6924 in the Search Area
6925
OPTIMIZE PRODUCTIVITY AND EXPAND YOUR PRACTICE From MedPod
The Medpod Medical Cart optimizes productivity and load balancing by enabling access to remote physicians during high volume periods or to reach low-density populations. Medpod’s proprietary software integrates with a wide range of professional medical devices and gives the remote provider control of the devices to conduct an examination that is on par with a face-to-face visit. Patient images, audio and data can be captured, annotated, tagged and uploaded in real-time or stored and forwarded into the EHR by either remote or local provider.
View Brochures, Videos & Mores at POR.io Enter Number 6925 in the Search Area
6926
ULTRA HCG COMBO TEST From Sekisui Diagnostics
The OSOM® Ultra hCG Combo test is a simple immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in serum or urine for the early confirmation of pregnancy. Internal studies have confirmed that the OSOM® Ultra hCG Combo test does not have a false negative result from hCG variants providing physicians with a higher level of confidence.
View Brochures, Videos & Mores at POR.io Enter Number 6926 in the Search Area
16
www.PhysiciansOfficeResource.com
INTRODUCING THE NEW AFINION™ 2 ANALYZER
Simply more efficient.
6927
The Afinion 2 Analyzer provides POC A1C results in 3 minutes and ACR results in 5 minutes enabling face to face consultations and more timely treatment decisions. TM
Highly accurate nn CLIA waived for A1C nn Quantitative results nn
No manual calibration required nn Ready to use controls nn
For more information or to request a demo on the Afinion 2 Analyzer please call 1-888-883-7692. abbott.com/poct Š 2019 Abbott. All Rights Reserved. All other trademarks referenced are trademarks of their respective owners. CVD187058 10004634 01/19
!25
6928
CLIA-WAIVED BIOFIRE® FILMARRAY® RESPIRATORY PANEL (RP) EZ
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
From BioFire
The BioFire RP EZ accurately detects and identifies 14 viral and bacterial pathogens—not just Flu A and Flu B— so you can provide your patients with the right treatment, the first time. The test is easy and can be performed right in your office or clinic, with results in about an hour. The BioFire RP EZ is designed to run on a single computer/ instrument configuration (EZ Configuration) of the BioFire® FilmArray® 2.0 System.
View Brochures, Videos & Mores at POR.io Enter Number 6928 in the Search Area
BIOFIRE® FILMARRAY® TORCH
6929
From BioFire
The BioFire® FilmArray® Torch is a fully integrated, random, and continuous access system designed to meet your laboratory’s syndromic infectious disease testing needs. The BioFire Torch offers a radically reduced benchtop footprint, saving precious space in the lab, and its scalability meets high throughput demands. BioFire® FilmArray® Link Software automatically uploads patient results. Fully compatible with all CLIA Moderate BioFire® FilmArray® Panels, the BioFire Torch helps you maximize efficiency and productivity.
View Brochures, Videos & Mores at POR.io Enter Number 6929 in the Search Area
CLIA-WAIVED FOR RAPID DETECTION OF FLU A+B 6930
From BD Veritor
The CLIA-Waved BD Veritor™ Plus System for rapid detection of Flu A+B, combines speed and accuracy. It provides clear digital results in under 11 minutes and has demonstrated performance compared to molecular tests.[1] It is easy to use and has a low cost of ownership. The BD Veritor ™ Plus System is CLIA-Waved for Flu, RSV and Group A Strep. [1] (BD Veritor System for Rapid Detection of Flu A+B, CLIA-waved kit package insert, 8087667 (14) 2018-06. BD Veritor System for Rapid Detection of Flu A+B, laboratory kit package insert, 8087666 (11) 2017-10., 2018-06.)
View Brochures, Videos & Mores at POR.io Enter Number 6930 in the Search Area 18
www.PhysiciansOfficeResource.com
The Adview 2 is still the only truly modular diagnostic station that grows with your needs. Start with blood pressure and choose temperature or pulse oximetry option at the time of purchase.
Bionet CardioCare 2000: $1,255.00 Schiller AT-2 Plus: $2,275.00* *add Spirometry: $1,000.00 Burdick ELI 250c: $3,188.00 Welch Allyn CP150 w/ Interp: $3,258.00
6931
6932
6935
6933
6934
6936
6937 6938
6939
6941
6942
6943
6944
Coaxial Ophth, Fiber Optic Oto, Speucla Dispenser, Aneroid BP, Wall Transformer and Wall Board without Thermometer: $979.00 with Thermometer: $1,416.00
6940
6945
TURN SMALL PLACES INTO SMART SPACES From Abbott
With reduced budgets, shrinking laboratory space and staffing challenges, many laboratories need a solution that lets them work smarter with less. The CELL-DYN Emerald 22 AL is a full performance, automated optical 5-part differential analyzer that delivers smarter results for small to midsize clinical laboratories. • Compact Design • Walkaway Functionality • Ease Of Use • Smart Safety Features
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
View Brochures, Videos & Mores at POR.io Enter Number 6945 in the Search Area
6946
SINGLE, INTEGRATED POC TESTING SOLUTION From Abbott Point of Care
The fully automated i-STAT System offers a broad menu of tests for diagnostic and treatment indicators related to disease state management and clinical practice guidelines. Using just 2 or 3 drops of blood, the system provides timesensitive tests at the patient’s side in just minutes.
View Brochures, Videos & Mores at POR.io Enter Number 6946 in the Search Area
6947
PENTRA 60 C+ HEMATOLOGY ANALYZER WITH 5-PART DIFFERENTIAL From HORIBA
Now you can have the same results hospitals and reference labs provide in a small, benchtop analyzer. The Pentra 60 C+ hematology analyzer provides a CBC with 5-part differential result using proprietary technology that ensures an accurate count and differential on the first run. Reduce repeats and reflex to the microscope with Pentra hematology technology.
View Brochures, Videos & Mores at POR.io Enter Number 6947 in the Search Area
20
www.PhysiciansOfficeResource.com
6950 6951
6949
6948
6952
6956
6960
6964
6953
6955
6954
6957
6961
6965
6959
6958
6962
6966
6963
6967
2019 Issue 9
PHYSICIANS office RESOURCE
THE IMPORTANCE OF RSV TESTING Sekesui Diagnostics Many Americans have probably never heard of respiratory syncytial virus (RSV), despite the fact that the CDC issued a warning in late 2018 cautioning parents of children under age one to monitor symptoms that could indicate RSV. Likewise, just as it tracks the flu every year, the CDC also monitors the total number of RSV tests performed at participating labs nationwide. The CDC calls RSV a common respiratory virus that usually causes mild, cold-like symptoms. While most individuals easily recover without medical intervention, it can lead to serious health problems in infants and older adults. In 2017 the World Health Organization (WHO) estimated that RSV causes around 33 million serious respiratory infections a year. This results in more than 3 million hospitalizations and nearly 60,000 deaths in children under 5 years of age every year. Nearly half of these hospitalizations and deaths are in children under 6 months of age. Parents of young children are more likely to be familiar with RSV, but all ages are affected. Because it’s often mistaken as the flu, it’s only recently that researchers have gained an understanding of its impact on the elderly. RSV infections can spread rapidly among older adults living in communal settings, infecting 5% to 10% of nursing home residents per year, causing death in 2% to 5% of cases. The Difficulty in Diagnosis There is an overlap of symptoms with many upper respiratory diseases such as cold and flu. Because of the overlap in symptoms and timing, clinicians must take care when making a diagnosis. Symptoms of RSV include runny nose, decrease in appetite, coughing, sneezing, fever, wheezing. Symptoms typically do not appear simultaneously, and in very young infants the only symptoms may be irritability, decreased activity, and breathing difficulties. While most people recover within one to two weeks, RSV can cause more severe infections. Young children, premature babies, the 22 www.PhysiciansOfficeResource.com
elderly, those with compromised immune systems, and those with other underlying health conditions are at a higher risk for these types of complications. Diagnosis & Treatment RSV can occur at any time, but it’s more likely in colder months of the year. Mild RSV infections can be treated with over-thecounter medications to help with symptoms and control fever. More severe cases may require supplemental oxygen, intravenous fluids, and bronchodilators. Researchers are working to develop vaccines and antivirals, but while there are up to 60 vaccines currently in development with 16 candidates in clinical development, none of these vaccine candidates have made it to market. Because RSV can more severely impact children and the elderly, proper diagnosis is important. Molecular testing is appropriate for all age groups. While immunoassays are proficient at diagnosing infants and/or adults, there is a growing need for testing in the elderly population. Each year an estimated 177,000 older adults are hospitalized and 14,000 of them die in the United States due to RSV infection. Sekisui Diagnostics is aware of the challenges in RSV testing and is excited to soon launch the SilarisTM RSV molecular test which will be available for the next RSV season. Sekisui also offers the OSOM® RSV/Adeno test, which is available in Europe, the Middle East, and Africa. This rapid chromatographic immunoassay is for the qualitative detection of Respiratory Syncytial Virus (RSV) and/or Adenovirus antigens directly from nasal swabs or nasal suction fluid. Testing at the point-of-care enables physicians to make the best treatment decisions possible when patients need it most. While most patients will recover from RSV without intervention, the most vulnerable patients—infants and the elderly—benefit from rapid results that allow for optimized treatment.
Molecular testing in the palm of your hand. SILARIS® FLU A&B AND RSV TESTS True molecular PCR technology in a rapid lateral flow format at the point-of-care. ®
For information please visit us at silaris.com
6968
37, 16-05 re 6 8 8 Call 8 n 2, for mo Optio ormation inf
For In Vitro Diagnostic Use Only © 2019 Sekisui Diagnostics, LLC. All rights reserved. Silaris® is a registered trademark of Sekisui Diagnostics, LLC. Because every result matters™ is a trademark of Sekisui Diagnostics, LLC.
2019 Issue 9
PRODUCTFOCUS 6969
MEMORY LOSS BIOMARKERS TO AID IN DIAGNOSIS IN PRIMARY CARE PRACTICES
PHYSICIANS office RESOURCE
From Evoke Neuroscience
The eVox® System is an FDA 510(k) cleared medical device to aid primary and specialty care physicians in diagnosis of memory loss and other cognitive disorders. eVox® measures memory loss biomarkers that may aid in detecting memory loss sooner, identifying the root cause of memory loss, and performing a differential diagnosis. eVox® procedures are performed in-office and are reimbursable by Medicare and commercial payers.
View Brochures, Videos & Mores at POR.io Enter Number 6969 in the Search Area
6970
MAKE LABORATORY COMPLIANCE AND INSPECTION EASIER From My Inspection
Make laboratory compliance and inspections easier by changing how you document, save and retrieve all information necessary to meet CLIA and accreditation regulations. With two unique electronic tools My Compliance Manual and MyInspection™ Software, the guesswork and tedious task of interpreting and documenting policy, procedure, forms, charts and logs is over. Your lab will be compliant, have less paper, and be inspection ready.
View Brochures, Videos & Mores at POR.io Enter Number 6970 in the Search Area
PORTABLE, SINGLE CLICK OPERATION SPIROMETER From MicroDirect
6971
The MicroDirect SpiroUSB many features include single click operation of all main functions, full ATS/ERS test quality checks, real time Flow/Volume and Volume/Time traces, a choice of child incentive displays, choice of predicted values, estimated lung age, pre/post bronchodilator comparisons and can be used on multiple PC’s with dongle software protection key. The child incentive display and ATS quality checks ensure maximal results every time. Use with a laptop for true portability.
View Brochures, Videos & Mores at POR.io Enter Number 6971 in the Search Area 24
www.PhysiciansOfficeResource.com
MDescapes
FOUR SEASONS ANGUILLA
Sun-seeking vacationers eager to learn more about Caribbean island culture while unwinding on the property’s luxurious white sand beaches and tranquil blue waters will find plenty of reason to celebrate on Anguilla this summer.
The Experience Anguilla package provides extra value with a fifth night free plus all the following:
Complimentary daily breakfast in Coba for 2 (per bedroom) Complimentary Kids For All Seasons activities Children under 12 eat free with each paying adult Rates starting at USD 550 for a Resort View
Additional Details at MyMDescapes.com
Sept. 2019
• • • •
FOUR SEASONS ORLANDO Within the gates of Walt Disney World® Resort, discover Central Florida’s only resort to receive the coveted AAA Five Diamond Award. A perfect blend of Four Seasons experiences and Disney offerings––for family time, for romance, or special events. Create a Four Seasons-only getaway in Orlando, with golf, spa, dining and a fun-filled island for kids, or make the Resort your base for a Disney adventure. No one brings dreams to life quite like Four Seasons and the magic of Disney. Additional Details at MyMDescapes.com
$50 Daily Resort Activities Credit!
FOUR SEASONS COSTA RICA Nestled on a Pacific coast hillside and overlooking golden sand beaches, Four Seasons Resort Costa Rica at Peninsula Papagayo is your premier eco-adventure destination. This year, join us to experience Costa Rica’s renowned “pura vida” lifestyle and our exciting renovation. The Resort’s 181 guest rooms, suites and residences capture the exotic character of Costa Rica, with comfortable rattan and bamboo furnishings, local artwork and indigenous wood and stone finishes. Additional Details at MyMDescapes.com
Reserve 5 Nights in Luxurious Accommodations and Receive 2 Additional Nights On Us!
FOUR SEASONS PUNTA MITA Sunshine and perfect temperatures year round, a secret landscape of astonishing beauty and the Pacific Coast’s most scenic beach. This and much more awaits you at Four Seasons Resort Punta Mita. With 173 rooms including 32 suites (all suites with private plunge pools), an option for everybody is available. In addition, Four Seasons private 4 and 5 bedroom Villas offer the true home away from home experience. Additional Details at MyMDescapes.com
Receive a Third Night in Luxurious Accommodations FREE with Every Two Consecutive Paid Nights!
All offers on this page are subject to availability at the time of reservation. Limited Time Only. Offers may not be combined with any other promotions/program benefits/offers/savings. Subject to change without notice.
6972
DEFINING MOBILE TELEDIAGNOSTICS From MedPod
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
With the ability to deploy into a medical office in less than 2 minutes, MobileDoc is the ultimate portable practice. Revolutionary in its compact and mobile design, MobileDoc integrates best-in-class professional medical-grade devices with state-of-theart HD video and EHR connectivity. Physicians can provide care remotely that is on par or better than a face-to-face visit, including conducting basic exams, checking vitals, and performing specialty testing— shattering the boundaries of traditional care.
View Brochures, Videos & Mores at POR.io Enter Number 6972 in the Search Area
IDEAL SYSTEM FOR LOW-TO-MODERATE VOLUME LABORATORIES
6973
From Sekisui Diagnostics
The SK™500 chemistry instrument and SEKURE Reagents offer an ideal system for low-to-moderate volume laboratories seeking exceptional throughput with minimal use of space and water. The SK500 is a compact and efficient instrument with a full menu of reagents specifically designed for and packaged for the system
View Brochures, Videos & Mores at POR.io Enter Number 6973 in the Search Area
6974
PAD TESTING SYSTEMS IDEAL FOR PRIMARY CARE TO VASCULAR SPECIALISTS From Newman Medical
Your patients Trust You to find their PAD • You have many high risk patients, including anyone over 65 or diabetics or smokers • Even if they are unaware of their PAD, 25% will have a heart attack or stroke within 5 years if not managed • Patients often mistake symptoms of PAD for arthritis. simpleABI Cuff-Link systems are easy to learn and use • Push button remote, automatic calculations/waveforms • PC based – reports are easy to save and share Excellent Value and Reimbursements • One test per week pays off system in less than one year • Medicare reimbursements range from $80 to $220 depending on location and test
View Brochures, Videos & Mores at POR.io Enter Number 6974 in the Search Area 26
www.PhysiciansOfficeResource.com
YOU BELONG AT FOUR SEASONS ANGUILLA OWNERSHIP AS EASY AS THE ISLAND ITSELF Here on the welcoming island of Anguilla, the turquoise water and azure blue sky meet in harmonious accord. You anticipate the peace of Anguilla before you ever get on the plane, and upon arrival your remaining cares simply roll away with the Caribbean tide. World-renowned Four Seasons service and carefree luxury are yours to enjoy. We welcome you home. You belong.
DELUXE STUDIOS TO 5 BEDROOM VILLAS FROM $825,000 TO OVER $10 MILLION TO FIND OUT MORE OR PLAN A DISCOVERY WEEKEND, CALL +1 800 901 7079 OR EMAIL US AT INFO@ANGUILLAPRIVATERESIDENCES.COM
AnguillaPrivateResidences.com
This offer is not directed to residents in any state in which a registration is required but in which registration requirements have not yet been met, including, but not limited to, New Jersey. Recreational features and amenities described herein are subject to change periodically. Warning: the California Department of Real Estate has not examined this offering, including, but not limited to, the condition of title, the status of blanket liens on the project (if any), arrangements to assure project completion, escrow practices, control over project management, racially discriminatory practices (if any), terms, conditions, and price of the offer, control over annual assessments (if any), or the availability of water, services, utilities, or improvements. It may be advisable for you to consult an attorney or other knowledgeable professional who is familiar with real estate and a law in the country where this subdivision is situated. In New York, the complete offering terms are in an offering plan available from sponsor. File no. CD11-1029 (Resort Residences) and fi le no. H11-0007 (Villas). Four Seasons Private Residences Anguilla are not owned, developed or sold by Four Seasons Hotels limited or its affi liates (Four Seasons). The developer, an affi liate of Starwood Capital Group, uses the Four Seasons trademarks and tradenames under a license from Four Seasons Hotels limited. The marks “FOUR SEASONS,” “FOUR SEASONS HOTELS AND RESORTS,” any combination thereof and the Tree Design are registered trademarks of Four Seasons Hotels Limited in Canada and U.S.A. and of Four Seasons Hotels (Barbados) Ltd. elsewhere. © 2019
6975
MICROS ES 60 HEMATOLOGY ANALYZER WITH 3-PART DIFFERENTIAL From HORIBA
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
Simple to use and easy to maintain with a zero maintenance concept, the Micros ES 60 is a small tabletop hematology analyzer with an integrated data management system. The analyzer provides a CBC with 3-part differential result in less than 60 seconds using only 10 µL of sample. Connect to the LiteDM Patient Data Management System for an affordable way to consolidate patient results to one report.
View Brochures, Videos & Mores at POR.io Enter Number 6975 in the Search Area
HISTOFREEZER® PORTABLE CRYOSURGICAL SYSTEM From OraSure - Histofreezer
6976
Histofreezer® Portable Cryosurgical System offers medical professionals an easy and effective method to treat nine different types of skin lesions, including common, plantar and genital warts and other common benign skin lesions. Medical professionals in primary care, internal medicine, podiatry, ob/gyn and dermatology areas of care have either added Histofreezer® to their practice offering or replaced more invasive and less tolerated procedures with Histofreezer®.
View Brochures, Videos & Mores at POR.io Enter Number 6976 in the Search Area
6977
FULLY AUTOMATED QUANTITIVE IMMUNOASSAY ANALYZER From Sekisui
The FastPack® IP System is a fully automated quantitative immunoassay analyzer designed for use in the Physician Office laboratory. Utilizing sophisticated chemiluminescence technology, the FastPack® IP System provides the capability to produce complex immunoassay results in 12 minutes or less with a push of a button. Menu includes Vitamin D, Testosterone, TSH, Free T4 PSA and hCG.
View Brochures, Videos & Mores at POR.io Enter Number 6977 in the Search Area 28
www.PhysiciansOfficeResource.com
6978
6979
6980
6981
6982
THE RX DAYTONA+ From Randox
A bench-top, fully automated, random-access chemistry analyzer, providing routine and specialized testing with emergency STAT sampling functionality. Demonstrating unparalleled versatility, the RX daytona+ combines robust hardware and intuitive software with the world-class RX series test menu, including specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing. The RX daytona+ ensures unrivalled precision, reliability and accuracy for results you can trust.
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
View Brochures, Videos & Mores at POR.io Enter Number 6982 in the Search Area
PENTRA XLR HEMATOLOGY ANALYZER WITH 5-PART DIFFERENTIAL
6983
From HORIBA Medical
The Pentra XLR hematology analyzer with autoloader provides a CBC with 5-part Diff result using proprietary technology that ensures an accurate count and differential on the first run. The Pentra XLR also provides a complete menu of Retic parameters for treating oncology and anemia patients. The autoloader processes 80 samples an hour and provides random continuous access for mediumto high-volume clinics and rural or community hospitals.
View Brochures, Videos & Mores at POR.io Enter Number 6983 in the Search Area
6984
LAB-ACCURATE RESULTS FOR ACR AND HBA1C From Abbott
With its compact size and panel of tests, the Afinion 2 system is ideal for point-of-care testing in physician offices, clinics, community health centers and hospital out-patient clinics. From just a small urine or fingerstick whole blood sample, lab-accurate results for ACR and HbA1c are made available during the consultation.
View Brochures, Videos & Mores at POR.io Enter Number 6984 in the Search Area
30
www.PhysiciansOfficeResource.com
6986
6985
#5316
Call 888-522-9939 or Visit medpod.por.io for More Information
2019 Issue 9
PRODUCTFOCUS 6987
FIRE YOUR FINANCIAL ADVISOR
PHYSICIANS office RESOURCE
From White Coat Investor
Fire Your Financial Advisor is the course that should’ve been taught to you in college, medical school, or residency but never was. For 1/10th the price and half the time of hiring a professional financial planner, this course will take you from feeling anxious and having no plan to having a written financial plan you can follow the rest of your investing career as a professional and a retiree. Topics covered include insurance, investing, retirement planning, and much more. Learn more at whitecoatinvestor.com.
View Brochures, Videos & Mores at POR.io Enter Number 6987 in the Search Area
6988
MICROS HEMATOLOGY ANALYZER WITH 3-PART DIFFERENTIAL PLUS THE LITEDM From HORIBA
Is it viral or bacterial? A CBC with 3-part differential can provide the clues to help distinguish between viral and bacterial infections before you decide to treat. The Micros 60 Hematology analyzer provides a CBC with 3-part Diff result in less than 60 seconds using only 10 µL of sample. Connect to the LiteDM Patient Data Management System for an affordable way to consolidate patient results to one report.
View Brochures, Videos & Mores at POR.io Enter Number 6988 in the Search Area
6989
CLIA-WAIVED COMPREHENSIVE METABOLIC PANEL From Abbott Point of Care
The Piccolo Xpress™ point-of-care chemistry analyzer delivers comprehensive CLIA waived diagnostics to Physician Offices. In 3 easy steps, the Piccolo provides lab-accurate results in minutes from a menu of 29 general chemistry tests, including lipids, liver, kidney, metabolic and other specialty functions. By using only 100 microliters of whole blood, serum or plasma - physicians can make confident treatment decisions faster, thereby increasing the efficiency, throughput and capacity of their practice, while also increasing revenue and ensuring patient satisfaction.
View Brochures, Videos & Mores at POR.io Enter Number 6989 in the Search Area
32
www.PhysiciansOfficeResource.com
A better way.
They’re Here Flu, RSV, Strep. Be Ready.
With confirmatory molecular results,
Cepheid’s CLIA Waived test menu delivers peace of mind to you and your patients.
6990
6991
6992
Xpert Xpress Flu/RSV
Xpert Xpress Flu
Xpert Xpress Strep A
• One sample. One Cartridge. Three results
• Qualitative, molecular detection and differentiation of influenza A and B
• Accurate, real-time PCR molecular testing for Group A Strep
• Qualitative, molecular detection and differentiation of influenza A, influenza B and RSV
• Sample types include nasal swab and nasopharyngeal swab
• Internal QC in each cartridge
®
®
• Room Temperature reagent storage
®
• No confirmation required for negative results*
• Sample types include Nasal swab and Nasopharyngeal swab
For more information, call (888) 256-6990 For in vitro diagnostic use. * No culture confirmation required for negative results unless clinical symptoms persist, or there is an outbreak of acute rheumatic fever (ARF). 904 Caribbean Drive | Sunnyvale, CA 94089 USA | TOLL FREE +1.888.336.2743 | PHONE +1.408.541.4191 | FAX +1.408.541.4192 | www.cepheid.com
6993
ACCUTEST PH® PHENAPHTHAZINE PAPER From Jant Pharmacal
Test papers give instant, easy-to-read results, with clear, bright matches at 0.5 intervals from pH 4.5 to 7.5. Color charts are lab-tested for precision accuracy. Made in the U.S.A. with state-of-the-art materials. An FDA-listed medical test product, used in hospitals and doctor’s offices around the world. Economical – approximately 100 tests/roll. Widely used in hospitals and doctors’ offices to detect the presence of amniotic fluid in vaginal secretions during late-term pregnancy, a sign of premature amniotic sac rupture.
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
View Brochures, Videos & Mores at POR.io Enter Number 6993 in the Search Area
6994
PENTRA C400 CHEMISTRY ANALYZER From HORIBA Medical
One benchtop, not a whole lab! No water system, drain or special electrical connected required to operate the Pentra C400 chemistry analyzer. Now you can have the power of a floor model analyzer on the benchtop! The Pentra C400 chemistry system processes up to 420 tests/hr including ISEs and offers routine metabolic assays, TDMs, DAUs and Adulterants, HbA1c and Vitamin D tests. With 40 open channels, you can add much more for a complete menu to meet your practice needs.
View Brochures, Videos & Mores at POR.io Enter Number 6994 in the Search Area
SPOTCHEM™ EZ CHEMISTRY ANALYZER 6995
From Jant Pharmacal
SPOTCHEM™ EZ chemistry analyzer is a small bench top chemistry analyzer that utilizes dry chemistry technology to test whole blood. Results are available on the SPOTCHEM™ printer or downloaded via LIS. SPOTCHEM™ is ideally suited for small laboratories and physician offices that desire an easy-to-use analyzer with a small footprint. Maximum throughput is 48 tests per hour. Test menu includes 21 tests and 3 panels. Tests whole blood, serum or plasma with rapid results within 4 – 15 minutes. Extensive CLIA-waived menu, includes lipid panel, creatinine, AST, ALT, glucose, and 2 chemistry panels. Automatic calibration.
View Brochures, Videos & Mores at POR.io Enter Number 6995 in the Search Area 34
www.PhysiciansOfficeResource.com
Win a FREE iPad Mini!
Join POR as we conduct our first
in a series of brief surveys, designed to give a voice to providers. With
your help we can better understand what’s trending in physician offices,
laboratories, and healthcare facilities across America, and help improve
office and laboratory proficiency, profitability, and patient care.
As a Thank You, we’ll report the results from this and future surveys in Physicians Office Resource magazine. Moreover, we will enter you in our periodic drawing for a FREE Apple iPad, which you may gift to someone or keep for yourself. The more surveys completed, and the more questions you answer in each, the more chances you will have to win.
www.survey.por.io
2019 Issue 9
PHYSICIANS office RESOURCE
HEALTHY SKEPTICISM: HELPING PATIENTS HELP THEMSELVES ONLINE Dylan Chadwick, Staff Writer for Physicians Office Resource
These days, virtually any brick and mortar service has its own internet doppleganger. One can attain a college degree by attending online classes, stream movies directly from the source and of course, there’s Wikipedia, the online staple that’s put the final nail in the coffin of the door-to-door Encyclopedia industry. And while there’s seemingly no end to the wealth of information afforded to us on the internet, that information does come at a price: internet “quality control” is spotty at best. Now, that’s well and good, likely entry level information to anyone who’s ever written a term paper or sought out unbiased information in a Honda forum...but then again, internet literacy isn’t always a straightforward metric. In an article by Tanya Fenke MD, (Dr. Google Should Be Sued for Malpractice. Here’s Why), the author illustrates the inherent problem of taking all our health concerns to Google, namely that internet sources quickly become outdated, are biased towards their benefactors and constituents, aren’t often written by healthcare professionals and often lack traceable references. In fact, as the title dictates, she suggests that if Google were a physician, he or she should be sued for malpractice, based on the number of problems that disseminating false information causes (no word on Dr. Pepper and Dr. Feelgood’s prospects at the time of publication). While I wholeheartedly agree with Fenke’s assessment, that Google, or an internet search, isn’t a sustainable replacement for actual medical advice from an actual, living, breathing medical professional, I also realize the dilemma of Google’s involvement in everything. The trends 36
www.PhysiciansOfficeResource.com
of internet ubiquity aren’t going to slow, nor will Google’s lumbering ascent into total control of the internet cease. This isn’t glass half-empty philosophizing either, just the acceptance that if/when (more like when) the machines finally do take over, we can assume Google will be in the mix somewhere. Instead, it’s becoming important for physicians to not only be the conduits towards viable health information, but also to help patients establish good searching habits for when they come across health information on their own time. Physicians cannot dictate what their patients will read and see outside of the office, but by giving them the tools to sniff out what’s good and what probably needs a second opinion, they greatly reduce the number of faulty accidents and misunderstandings. Look for Recent Content Health information is subject to ongoing developments and research, on micro and macro scales. What was once the de-rigeur health fad or yesterday might have been proven total bunk today, and vice versa. In that regard, information on the internet can run a little bit dicey since (theoretically) anything put online stays online forever. Encourage patients to check their sources and to be wary of any sources from more than a few years old, particularly if it’s dispensing health advice. Even if the information has stayed the same, credible and reputable outlets will be sure to keep things current anyway. Additionally, the idea of timeliness opens up the discussion for physician blogging and social media, a great
way to create relevant and reputable content quickly, to update on information that is changing and to just generally maintain a current channel of communication. Patients should also be wary of information that doesn’t contain any dates as there’s no way to determine how recently it was obtained and published.
should maintain their skeptic senses a bit. Information can be sensationalized to drive ratings and page views to a site, and often take claims and facts out of context, specifically to fit their own content agenda. If a site doesn’t provide sources for its health care advice, isn’t from a health sanctioned organization or contains many sources from less credible sources, patients “Physicians cannot dictate shouldn’t accept the what their patients will read information sight unseen. Remember, and see outside of the office, if a site doesn’t but by giving them the tools want readers to to sniff out what’s good and know where they what probably needs a second got their stories, at opinion, they greatly reduce best they likely don’t the number of faulty accidents have anyone’s best interests in mind and misunderstandings.” and at worst, could Dylan Chadwick be hiding something.
Objectivity and Bias It can be difficult to look objectively at one’s own symptoms, especially when emotions are running strong and influencing one’s actions. In this regard, internet searching along various strings of keywords can push the user towards a “self-diagnosis” that is biased or at the very least a little skewed. This also introduces what I call the “WebMD” effect in which a person goes down the internet rabbit-hole of reading all symptoms associated with a certain disorder and slowly convinces themselves that they indeed have the disorder. No one is immune to momentary flashes of anxious grandiosity. Furthermore, there’s a wealth of “for profit” sources out there, posing as viable health professionals, even when they’re not. Wary patients should be mindful of any sites with corporate sponsors, as the information contained may just be a sideways plug to get you to buy a miracle product or to sell you on an affliction you don’t actually have. Solid health information is a right, and shouldn’t market you towards buying anything new. Experience and Credibility It goes without saying, but a number of those dispensing health care information are just writers….not doctors (this one included). In this regard, knowing exactly where a source comes from can be what will set off the “nonsense meter” right away. Patients should look for the credentials of an author who’s dispensing health care information, ensuring that they’re actual, medically licensed doctors. Even so, it’s not uncommon for professionals to get their articles ghost written by off-site writers. Patients should assume that any information coming from a source that doesn’t identify as a physician should probably not be regarded at all, and those that come from doctors, should be carefully vetted before following up on them. Sources and Citations In print, most must cite their sources, but on the internet, and it can be a bit more difficult to truly regulate this principle. If a site doesn’t cite the sources of its claims, or if they’re especially absolute or broad and sweeping, one
Encourage the In-Person Follow Up Fortunately, physicians still have the ultimate, and most credible, say in directing patients towards quality health care information. Besides endowing them with a dose of healthy skepticism towards online health information (and let’s be honest, it’s a good trait to have in an election year too), it’s important to remind them that they can always follow up directly with you, a primary health care source, about anything unclear. Not only does this type of outreach send the message that you’re there to help and guide them in their healthcare journey, but also establishes a precedent for always checking up with a qualified source before taking anything to heart.
Ultimately, we shouldn’t recognize Google as anything even remotely like a doctor and should recast it for what it really is: “a huge repository of information, scrupulously indexed and largely unregulated.” Patients and users still have the power. Read this and other articles at www.PhysiciansOfficeNews.com
37
6996
DRUGS OF ABUSE TESTING AND ROUTINE CHEMISTRY PANELS ON A SINGLE ANALYZER From Carolina Liquid Chemistries
PHYSICIANS office RESOURCE
2019 Issue 9
PRODUCTFOCUS
Carolina Liquid Chemistries Corp. announces the successful launch of Medica Corporation’s high-speed benchtop analyzer, the EasyRA®. The updated analyzer now operates at a photometric rate of up to 240 tests per hour or up to 480 tests per hour with ISE. The EasyRA urine drug screening and general chemistry reagents are CLIA categorized as moderately complex. This all-in-one system allows clinical laboratories to screen for drugs of abuse in urine while also allowing healthcare providers to assess routine chemistry panels on a single analyzer.
View Brochures, Videos & Mores at POR.io Enter Number 6996 in the Search Area
6997
THE BREWER CENTURY SERIES STOOL From Brewer
Has a pneumatic height adjustment, 16” wide, 4” thick poly-foam seat cushion, and five-leg 23” brushed aluminum accent base. Optional adjustable 18” chrome footing. Optional adjustable contoured backrest with black plastic shroud.
View Brochures, Videos & Mores at POR.io Enter Number 6997 in the Search Area
6998
ACCURATE, ACTIONABLE RESULTS FROM THE LEADER IN POINT-OF-CARE LIPID TESTING From Abbott
The CLIA-waived Alere Cholestech LDX™ Analyzer is engineered for confidence, providing accurate, actionable, and readily accessible results that have set the standard in point-of-care lipid profile, cholesterol, and glucose testing. Results are easy to obtain. Fingerstick sampling and a small sample size (40μL) makes results less painful and time consuming.
View Brochures, Videos & Mores at POR.io Enter Number 6998 in the Search Area
38
www.PhysiciansOfficeResource.com
It's flu season. Which test are you using?
Simplify workflow, results and patient management. The CLIA-Waived BD Veritor™ Plus System for Rapid Detection of Flu A+B simplifies workflow and provides clear and quick results for appropriate patient management within the same visit. • One button functionality, easy to use and implement • Unambiguous digital flu result in under 11 minutes* • Demonstrated performance compared to molecular tests1 • Low cost of ownership
Simply the right POC test for influenza, Group A Strep and RSV.†
6999
Request a demo today at go.bd.com/VeritorPOR *Results after 10-minute incubation period for Flu A+B and RSV; after 5-minute incubation period for Group A Strep † RSV- Respiratory Syncytial Virus References: 1. BD Veritor System for Rapid Detection of Flu A+B, CLIA-waived kit package insert, 8087667 (14) 2018-06. BD Veritor System for Rapid Detection of Flu A+B, laboratory kit package insert, 8087666 (11) 2017-10.
BD, 7 Loveton Circle, Sparks, MD 21152-0999 USA Tel: 1.888.211.6980 1.800.638.8663
© 2018 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.
40
www.PhysiciansOfficeResource.com
NEW
TURN SMALL PLACES INTO SMART SPACES With reduced budgets, shrinking laboratory space and staffing challenges, many laboratories need a solution that lets them work smarter with less. The CELL-DYN Emerald 22 AL is a full performance, automated, optical 5-part differential analyzer that delivers smarter results for small to mid-size clinical laboratories with: • Compact design maximizes valuable laboratory space • Ease of use and walkaway functionality optimizes staff time • Smart open tube sample device ensures user safety
41 cm
Visit www.corelaboratory.abbott/hematology to learn how the new CELL-DYN Emerald 22 AL can help your laboratory operate more efficiently. 50 cm
CH OOSE TRA NSF O RM ATION
TM
Achieve measurably better healthcare performance.
CELL-DYN Emerald 22 AL is a Class 1 laser. For in vitro diagnostic only. Refer to the Operator’s Manual for operational precautions, limitations, and hazards. CELL-DYN Emerald and CHOOSE TRANSFORMATION are trademarks of Abbott Laboratories in various jurisdictions. CAUTION: United States Federal law restricts this device to sale and distribution by or on the order of a physician, or to a clinical laboratory. © 2019 Abbott Laboratories. ADD-00064842.
7000